Risk & Insurance: You Need to Know Why PTSD Could Be Impacting Return to Work
After a traumatic event, injured workers may want to avoid the scene of the accident. But returning to work could help them heal.
After a traumatic event, injured workers may want to avoid the scene of the accident. But returning to work could help them heal.
Learn how connected claims data, AI and predictive analytics help claims teams identify risks earlier, improve decision-making and manage costs.
Throughout 2026, lawmakers and insurance regulators have increasingly turned their attention to how artificial intelligence (AI) is governed, particularly with decisions affecting consumers. Many proposed AI bills failed to advance this year, but the volume of legislative and regulatory activity sends a clear signal that regulators expect insurers to understand, oversee, and remain accountable for AI-supported activities.
Explore how Apricus streamlined catastrophic claim care coordination for a client. See how one point of contact aligned nursing, mobility equipment and housing.
Discover how Genex's Ticket to Work program helps disability carriers reduce SSA-related risks, support return to work and improve claim outcomes at no added cost.
Mitchell today announced plans to expand its collaboration with Tractable through a proposed, exclusive agreement focused on optimizing the vehicle intake process. By connecting Tractable’s LumaScanner vehicle inspection system with Mitchell’s automated estimating solution, Mitchell Intelligent Estimating, the companies intend to help North American multi-site operators (MSOs) and independent collision repair centers accelerate damage assessment and preliminary estimate creation.
Pharmaceutical products classified as "opportunistic" exploit pricing gaps and regulatory variability to drive disproportionate costs with little-to-no added clinical value. While opportunistic products represent a small fraction of overall prescription volume, their financial impact is significant. This trends analysis identifies where clinical and cost interventions can have the greatest impact.